Modest growth in global antibacterial drugs market, report predicts

5 October 2021

The global antibacterial drugs market is projected to grow at a modest compound annual growth rate (CAGR) of 2.6% between 2021 and 2031, according to a Fact MR report.

In the short term, the market will expand at a CAGR of 1.5% from 2020 to 2025 to reach $50 billion, while by 2031 it will be worth $62 billion, the report predicts.

Historically, the market experienced sluggish growth, registering a 1% value CAGR from 2016 to 2020. At the end of this period, it was valued at around $46 billion.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK